Introduction
Toll-like receptors (TLRs) are pattern recognition receptors that detect infectious microbial components and mount immune responses. 1 They can also respond to endogenous host molecules derived from damaged tissue as part of the tissue repair process. 2 They are type I transmembrane receptors with extracellular leucine-rich repeat motifs, a transmembrane domain and an intracellular Toll/interleukin-1 receptor homology domain. To date, at least 13 members of the TLR family, with different ligand specificities, have been identified. The TLRs are mainly expressed in immune cells, including monocytes, macrophages, dendritic cells and B cells, and have critical roles in regulating immune and inflammatory responses. It is now well established that they are intimately involved in the development and progression of various inflammatory diseases, including atherosclerosis, rheumatoid arthritis and cancer. [3] [4] [5] Hypoxia plays an important role in regulating a variety of physiological responses as well as in pathological situations. 6 At sites of inflammation, tissue oxygen levels decrease and generate hypoxic stress, which further aggravates and accelerates inflammation and tissue damage.
Summary
Toll-like receptors (TLRs) are germline-encoded innate immune receptors that recognize invading micro-organisms and induce immune and inflammatory responses. Deregulation of TLRs is known to be closely linked to various immune disorders and inflammatory diseases. Cells at sites of inflammation are exposed to hypoxic stress, which further aggravates inflammatory processes. We have examined if hypoxic stress modulates the TLR activity of macrophages. Hypoxia and CoCl 2 (a hypoxia mimetic) enhanced the expression of TLR4 messenger RNA and protein in macrophages (RAW264.7 cells), whereas the messenger RNA of other TLRs was not increased. To determine the underlying mechanism, we investigated the role of hypoxia-inducible factor 1 (HIF-1) in the regulation of TLR4 expression. Knockdown of HIF-1a expression by small interfering RNA inhibited hypoxia-induced and CoCl 2 -induced TLR4 expression in macrophages, while over-expression of HIF-1a potentiated TLR4 expression. Chromatin immunoprecipitation assays revealed that HIF-1a binds to the TLR4 promoter region under hypoxic conditions. In addition, deletion or mutation of a putative HIF-1-binding motif in the TLR4 promoter greatly attenuated HIF-1a-induced TLR4 promoter reporter expression. Up-regulation of TLR4 expression by hypoxic stress enhanced the response of macrophages to lipopolysaccharide, resulting in increased expression of cyclooxygenase-2, interleukin-6, regulated on activation normal T cell expressed and secreted, and interferon-inducible protein-10. These results demonstrate that TLR4 expression in macrophages is up-regulated via HIF-1 in response to hypoxic stress, suggesting that hypoxic stress at sites of inflammation enhances susceptibility to subsequent infection and inflammatory signals by up-regulating TLR4. 
Hypoxia-inducible factor 1 (HIF-1) is a major transcription factor activated during hypoxia that plays critical roles in inducing hypoxia-related gene expression and cellular responses. 7, 8 It is a heterodimeric protein that consists of HIF-1b and HIF-1a. 9 While HIF-1b is constitutively expressed, HIF-1a is tightly regulated by oxygen. Therefore, the overall activity of HIF-1 is dictated by the intracellular HIF-1a level. Oxygen-activated prolyl hydroxylases hydroxylate HIF-1a at proline residues (402 and 564) within an oxygen-dependent degradation domain. This hydroxylation drives HIF-1a toward ubiquitylation by E3 ubiquitin protein ligase, which is part of the von Hippel-Lindau tumour suppressor protein complex, resulting in the rapid degradation of ubiquitylated HIF-1a. 10, 11 Under hypoxic conditions, the enzymatic activity of prolyl hydroxylases is significantly reduced because oxygen is a necessary substrate for its activity. As a result, HIF-1a accumulates and HIF-1 activity is upregulated. It has been recently proposed that hypoxia is an inflammatogen, as it can induce the activation of macrophages, which are major cellular sources of inflammatory mediators in the immune system. 12, 13 Toll-like receptor 4 is reported to be associated with a risk of hypoxia-related diseases, and its expression is upregulated in the tissues of patients with myocardial ischaemia-reperfusion injury. 14 The signs of inflammatory responses and pathological changes upon ischaemic injury in various tissues, including heart, kidney, brain and lung, are significantly decreased in TLR4-deficient mice. [15] [16] [17] [18] Hypoxia increases TLR4 expression in microglial cells and lowers it in endothelial cells. 19, 20 These findings suggest that controlling TLR4 activity could be a useful strategy for decreasing inflammatory responses aggravated by hypoxic stress. However, the mechanism of which hypoxic stress affects TLR4 activation is not fully understood.
We have investigated the mechanism underlying the regulation of TLR4 by hypoxic stress in immune cells. We found that the hypoxia-induced increase in expression of TLR4 in macrophages is mediated at least in part via HIF-1. Our observations also suggest that the increased expression of TLR4 in macrophages under hypoxic stress enhances the susceptibility of the immune system to subsequent infection and inflammatory signals. Regulation of TLR4 expression may therefore represent a novel therapeutic target in a number of pathological states that can be induced by hypoxia.
Materials and methods

Reagents and plasmids
Purified lipopolysaccharide (LPS) from Escherichia coli was obtained from List Biological Laboratories Inc. (Campbell, CA). Cobalt chloride (CoCl 2 ) was purchased from Sigma-Aldrich (St Louis, MO) and dissolved in endotoxin-free water. Antibody against cyclooxygenase-2 (COX-2) was purchased from Cayman (Ann Arbor, MI). Antibody against actin was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). All other reagents were purchased from Sigma-Aldrich, unless otherwise stated. The HIF-1a expression plasmid was a gift from Dr L. Eric Huang (University of Utah School of Medicine, UT). Luciferase reporter plasmids containing the TLR4 promoter () 102/+ 223 and ) 518/+ 223) were obtained from Dr Thierry Roger (University of Lausanne, Switzerland). A mutated TLR4 promoter luciferase reporter plasmid () 518/+ 223) with CGTG changed to AAAG () 407 to ) 404) was prepared by site-directed mutagenesis and confirmed by DNA sequencing. The heat-shock protein 70-galactosidase reporter plasmid was from Dr Robert Modlin (University of California, Los Angeles, CA). All DNA constructs were prepared on a large scale using an EndoFree plasmid Maxi kit (Qiagen, Chatsworth, CA) for transfection.
Cell culture
RAW264.7 murine macrophage cells (ATCC TIB-71) were obtained from the American Type Culture Collection (Manassas, VA). The cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% (volume/volume) heat-inactivated fetal bovine serum (Hyclone, Logan, UT), 100 units/ml penicillin and 100 lg/ml streptomycin (Hyclone). They were maintained at 37°in a 5% CO 2 /air environment. To generate hypoxic stress conditions, cells were placed in an air-tight chamber with inflow and outflow valves infused with a gas mixture (5% CO 2 , 10% H 2 , 85% N 2 ) maintaining a low oxygen tension (< 1%), or treated with 100 lM CoCl 2 , which has been widely used to induce hypoxic stress.
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Reverse transcription-polymerase chain reaction analysis Total RNAs were extracted with WelprepÔ reagent (Jeil Biotechservice Inc., Daegu, Korea). The RNAs were reverse-transcribed with UmProm-IIÔ Reverse Transcriptase (Promega, Madison, WI) and amplified with an IQÔ5 (Bio-Rad, Hercules, CA) using Taq DNA polymerase (Solgent, Daejeon, Korea) for routine polymerase chain reaction (PCR), and IQÔ SYBR Ò Green Supermix (Bio-Rad) for quantitative real-time PCR. The primers were: Tlr2, 0 . The specificity of the amplified PCR products was assessed by a melting curve analysis. Fold inductions of gene expression were calculated as previously described. 22 Flow cytometric analysis RAW264.7 cells were labelled with mouse phycoerythrin (PE)-conjugated anti-mouse TLR4 antibody and mouse PE-conjugated isotype immunoglobulin G1j (IgG1j) antibody as an isotype control (eBioscience, San Diego, CA). All staining procedures were performed at 4°in Pharmingen Stain Buffer (BD Pharmingen, San Diego, CA). Cells were analysed by flow cytometry using an EPICS XL-MCL (Beckman Coulter, Fullerton, CA). 
Immunostaining and confocal imaging analysis
RNA interference
Transfection of small interfering RNA (siRNA) into RAW264.7 cells was performed with RNAiMaxÔ reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. Mouse-specific HIF-1a siRNA and nontargeting control siRNA were synthesized and purified by Bioneer Co. (Daejeon, Korea). The sequences were as follows: HIF-1a siRNA, 5
0 -AAGCAUUUCUCUCAUUUC CUCAUGG-3 0 ; control siRNA, 5 0 -GACUACUGGUCGU-UGAACU-3 0 .
Transfection and luciferase assay RAW264.7 cells were transfected with a luciferase plasmid and a HIF-1a expression plasmid using SuperFect transfection reagent (Qiagen, Valencia, CA) according to the manufacturer's instructions. A heat-shock protein 70-b-galactosidase plasmid was co-transfected as an internal control. Total amounts of transfected plasmids were equalized by supplementing with the corresponding empty vector. Luciferase and b-galactosidase enzyme activities were determined using the Luciferase Assay System and b-galactosidase Enzyme System (Promega). Luciferase activity was normalized by b-galactosidase activity.
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assays were performed using a ChIP assay kit (Upstate Biotechnology, Lake Placid, NY). RAW264.7 cells were treated with 100 lM CoCl 2 for 8 hr. Cells were fixed with formaldehyde, lysed and sonicated to obtain DNA fragments of 200 to 1000 base pairs. Chromatin was then immunoprecipitated with anti-HIF-1a antibody (Novus Biology, Littleton, CO) or rabbit IgG overnight at 4°. Protein G agarose (Upstate Biotechnology) was added and incubated for 1 hr at 4°. The PCR was performed with TLR4 promoter-specific or vascular endothelial growth factor (VEGF) promoter-specific primers spanning the putative HIF-1 binding site. The primers for the TLR4 promoter were 5 0 -TGAGAACTGCAGAAGGCACTCAA-3 0 and 5 0 -AACTGGCGTGGAGCAACATCCTC-3 0 , yielding a 357-base-pair product. The VEGF promoter-specific primers spanning the HIF-1 binding site were 5
0 -TGAATCACC-ATGCCGGCCTGG-3 0 and 5 0 -AGCTAGGGCCCTGGG-GTGAAT-3 0 yielding a 333-base-pair product. As a loading control, PCR was carried out directly with input DNA purified from chromatin before immunoprecipitation. Quantitative real-time PCR analysis was performed to determine fold induction of HIF-1a binding to each promoter. A DCt 2 value was calculated for each sample by subtracting the Ct value for the input (total DNA) from the Ct value obtained from samples immunoprecipitated with specific antibody. A DCt 1 value was calculated by subtracting the Ct value for the input (total DNA) from the Ct value for samples immunoprecipitated with rabbit IgG as a control. DDCt was obtained by subtracting DCt 2 from DCt 1 . Fold differences were calculated using the formula, 2
DDCt because one cycle difference is equivalent to a two-fold difference in amplification.
Immunoblotting
Solubilized proteins were subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride membrane. The membranes were immunoblotted with the indicated primary antibody, followed by secondary antibody coupled to horseradish peroxidase. The reactive bands were visualized with an enhanced chemiluminescence system (Amersham Bioscience, Piscataway, NJ).
Enzyme-linked immunosorbent assays
Protein levels of interleukin-6 (IL-6), regulated on activation normal T cell expressed and secreted (RANTES), and interferon-inducible protein-10 (IP-10) were determined using an enzyme-linked immunosorbent assay kit for each cytokine according to the manufacturer's instructions (R&D Systems, Minneapolis, MN). The concentration ranges for the standard curves were from 7Á8 to 500 pg/ml for IL-6 and RANTES and from 31Á2 to 2000 pg/ml for IP-10. The mean minimum detectable dose of IL-6 and IP-10 was 1Á6 and 2Á2 pg/ml, respectively. The minimum detectable dose of RANTES was typically < 2 pg/ml.
Statistical analysis
Data are expressed as means ± SEM. Comparisons of data between groups were made using Student's t-test. Values of P < 0Á05 were considered significant.
Results
Hypoxic stress induces expression of TLR4 in macrophages
To investigate the effect of hypoxic stress on the expression of TLRs in macrophages, RAW264.7 cells were exposed to hypoxia or treated with CoCl 2 (a mimetic of hypoxia). Both hypoxia and CoCl 2 increased the levels of TLR4 messenger RNA (mRNA) in a time-dependent manner whereas mRNA levels of other TLRs were not enhanced (Fig. 1a,b) . Instead, the level of TLR9 tended to decrease in response to hypoxia or CoCl 2 . TLR4 protein expression was also enhanced by hypoxia and CoCl 2 (Fig. 1c,d ).
Hypoxic stress-induced TLR4 expression is mediated through HIF-1 To investigate the mechanism by which TLR4 expression is enhanced by hypoxic stress, we tested if HIF-1 was involved, using siRNA. HIF-1 is a major transcription factor regulating hypoxia-mediated gene expression and cellular responses. Up-regulation of TLR4 mRNA induced by hypoxia or CoCl 2 was significantly attenuated when HIF-1a expression was knocked down by siRNA transfection (Fig. 2a) . Consistent with this, the HIF-1a siRNA also decreased TLR4 protein expression in response to CoCl 2 (Fig. 2b) . The siRNA targeting HIF-1a reduced the level of HIF-1a mRNA, but not HIF-2a mRNA, indicating the gene specificity (Fig. S1 ). To confirm the involvement of HIF-1 in TLR4 expression, we took a gain-of-function approach by over-expressing HIF1a using HIF-1a plasmid. Transfection of HIF-1a expression plasmid resulted in the increased protein level of nuclear translocated HIF-1a in cells under hypoxic conditions (lane 4 in Fig. S2 ) compared with mock-transfected cells under hypoxic conditions (lane 2 in Fig. S2 ). Overexpression of HIF-1a increased luciferase reporter expression driven by the TLR4 promoter, as well as TLR4 mRNA levels, in macrophages treated with CoCl 2 (Fig. 3a,b) . In contrast, HIF-1a over-expression in macrophages in the absence of CoCl 2 exposure did not enhance reporter expression and TLR4 transcript levels, probably because of the rapid degradation of HIF-1a in normoxic conditions (Fig. 3a,b) . Consistently, nuclear translocation of HIF-1a was observed only when cells were treated with CoCl 2 (Fig. S2 ). These observations suggest that HIF-1a contributes to TLR4 expression under hypoxic conditions in which the level of HIF-1a protein is maintained.
To see if HIF-1 binds to the TLR4 promoter, we performed ChIP assays in macrophages treated with CoCl 2 , using a specific antibody against HIF-1a. We present the result of ChIP assays using the VEGF promoter as a positive control because VEGF expression is known to be regulated by HIF-1. 23 The ChIP assays followed by PCR were performed with specific primers for the TLR4 or VEGF promoter and revealed that HIF-1a bound to the TLR4 promoter as well as the VEGF promoter (Fig. 3c) . These results showed that HIF-1 can transcriptionally regulate TLR4 expression under hypoxic conditions by direct binding to the TLR4 promoter region. The consensus sequence of the hypoxia-responsive element (HRE) is 5 0 -CGTG-3 0 , 9 and the proximal region of the mouse TLR4 promoter has a putative HRE located at ) 407 to ) 404 (Fig. 3d) . To determine if the putative HRE is important for TLR4 expression under hypoxic stress, we used a TLR4 promoter construct mutated in the putative HRE (CGTG to AAAG at ) 407 to ) 404) and a deletion mutant that contains the TLR4 promoter region up to ) 102, in addition to a wild-type TLR4 promoter construct. While luciferase reporter expression was induced by HIF-1a in macrophages transfected with the wild-type construct, this effect was greatly diminished when the putative HRE was mutated or deleted (Fig. 3d) . This indicates that the putative HRE located at ) 407 to ) 404 is involved in HIF-1-mediated TLR4 expression.
Macrophages exposed to hypoxic stress show enhanced responsiveness to LPS
To address the effect of enhanced TLR4 expression under hypoxic stress, we investigated if the responsiveness of macrophages to a TLR4 agonist was increased when cells were exposed to hypoxic stress. After RAW264.7 cells had been exposed to hypoxia for 8 hr to increase TLR4 expression, the cells were stimulated with a TLR4 agonist (LPS) under normoxic conditions to avoid a possible direct effect of hypoxia on the parameters examined. Both mRNA and protein levels of COX-2, IL-6 and RANTES induced by LPS were found to be potentiated by preexposure to hypoxia or CoCl 2 ( Fig. 4a-h ). The IP-10 mRNA induced by LPS was also greatly enhanced (Fig. 4i) . While we could observe the increase in protein levels of COX-2, IL-6 and RANTES by LPS treatment for 8 hr in macrophages, the protein level of IP-10 was not increased by LPS treatment (1 ng/ml) for 8 hr in macrophages (vehicle versus LPS, 170 ± 5Á5 versus 160 ± 3Á9 pg/ml). Evidently hypoxic stress augments the responsiveness of macrophages to bacterial components as a result of the increased TLR4 expression. This suggests that the higher TLR4 levels in macrophages under hypoxic stress contribute to the aggravated inflammatory responses and enhanced cellular susceptibility to subsequent bacterial infection.
Discussion
Expression of TLRs is not static but rather is modulated dynamically in response to pathogens, a variety of cytokines, and environmental stresses. In particular, regulation of TLR4 levels at infected sites can be critical for appropriate immune and inflammatory responses. In infected and inflamed sites, oxygen levels decrease and generate a hypoxic state because of the massive metabolic oxygen consumption by surrounding cells. This results in changes of the signalling pathways and gene expression related to physiological responses as well as to pathological events. [6] [7] [8] We have demonstrated that expression of TLR4 was upregulated in macrophages exposed to hypoxic stress. While up-regulation of TLR4 mRNA in macrophages was observed after exposure to 2 or 4 hr of hypoxic stress in our study, Ishida et al. 20 reported that relatively long-term hypoxia for 48-72 hr diminished TLR4 expression as a result of mitochondrial generation of reactive oxygen Figure 2 . Knockdown of hypoxia-inducible factor 1a (HIF-1a) leads to attenuation of hypoxic stress-induced Toll-like receptor 4 (TLR4) expression. RAW264.7 cells transfected with either small interfering RNA (siRNA) targeting HIF-1a or control siRNA were exposed to normoxia (20% O 2 ) or hypoxia (< 1% O 2 ) or treated with CoCl 2 (100 lm) for 8 hr. (a) TLR4 messenger RNA levels were determined by quantitative real-time polymerase chain reaction analysis. (b) TLR4 expression was analysed by flow cytometry. Values are means ± SEM (n = 3-4). **P < 0Á01; ***P < 0Á001. Veh, vehicle. Luc pHRE-deleted Figure 3 . Hypoxic stress-induced Toll-like receptor 4 (TLR4) expression is transcriptionally regulated by hypoxia-inducible factor 1a (HIF-1a). (a) RAW264.7 cells were cotransfected with a luciferase construct driven by the TLR4 promoter () 518/+ 223) and an expression plasmid for HIF-1a, and treated with CoCl 2 (100 lm) for 24 hr. Cell lysates were analysed for luciferase activities. Relative luciferase activity (RLA) was calculated after normalization with b-galactosidase activity. (b) RAW264.7 cells were transfected with the HIF-1a expression plasmid and treated with CoCl 2 (100 lm) for 8 hr. TLR4 messenger RNA levels were determined by quantitative real-time polymerase chain reaction (PCR) analysis. (c) RAW264.7 cells were incubated with CoCl 2 (100 lm) for 8 hr, and chromatin immunoprecipitation (ChIP) assays followed by PCR were performed using HIF-1a antibody and specific primers for the TLR4 promoter or the vascular endothelial growth factor (VEGF) promoter (positive control). RAW264.7 cells were cotransfected with the HIF-1a expression plasmid and luciferase constructs driven by the wild-type TLR4 promoter () 518/+ 223), a TLR4 promoter mutated at a putative hypoxia-responsive element (pHRE) or a pHRE-deleted promoter () 102/+ 223), and then incubated with CoCl 2 (100 lm) for 24 hr. Values are means ± SEM (n = 3). *P < 0Á05; **P < 0Á01; ***P < 0Á001. Veh, vehicle. species in human umbilical vein endothelial cells. Kuhlicke et al. 24 showed that protein expression of TLR2 and TLR6 was increased by relatively long-term hypoxia for 24-72 hr in human microvascular endothelial cells, while the TLR4 mRNA level at 24 hr was not changed by hypoxic stress in bone-marrow-derived dendritic cells. Although differences in the duration of hypoxia and the types of cells may account for differential cellular responses in TLR expression, these results suggest that expression of TLRs such as TLR4 and TLR2 can be dynamically regulated by hypoxic stress. Consistent with our results, many in vivo experimental and clinical studies demonstrated that TLR4 expression was elevated in cells and tissues of hypoxia-related disease. The levels of TLR4 mRNA and protein were increased in murine hearts after myocardial ischaemic injury, and in human hearts derived from patients with dilated cardiomyopathy and myocarditis. 14, 25 In addition, TLR4 expression was significantly increased in Kupffer cells in rat liver grafts, and in tubular epithelial cells and infiltrating leucocytes within the kidney following ischaemia. 16, 26 Expression of TLR4 was observed in murine and human lipid-rich atherosclerotic lesions, while normal aortic tissues showed no or minimal expression. 27 These findings suggest that TLR4 plays critical roles in the pathology of hypoxia-related diseases. Indeed, it has been reported that TLR4 activation is important for inflammatory and pathological responses induced by ischaemic injury in various tissues. Mice that are TLR4-deficient are reported to have minor infarctions and reduced inflammatory responses after brain ischaemic injury. 15 The TLR4-deficient mice were also protected against kidney dysfunction after kidney ischaemic injury, with lowered expression of pro-inflammatory cytokines and chemokines. 16 After lung ischaemia-reperfusion injury, lungs from TLR4-deficient mice showed a marked reduction in vascular permeability, lung myeloperoxidase activity, bronchoalveolar lavage leucocyte accumulation, and bronchoalveolar lavage cytokines/chemokines secretion compared with the lungs of wild-type mice. 17 Deficiency or functional mutation of TLR4 in mice resulted in reduced myocardial infarction size and signs of inflammatory response after myocardial ischaemia-reperfusion injury.
18 Our results also demonstrate that the expression of inflammatory mediators is greatly augmented in macrophages exposed to hypoxic stress because of the elevated level of TLR4 expression in hypoxic states. These findings all indicate that hypoxic stress can aggravate inflammatory responses to infecting bacteria by up-regulating TLR4 expression in macrophages. They further suggest that TLR4 activity and innate immunity are involved in the organ damage and inflammatory process of ischaemia-related diseases. It has not been entirely clear which transcriptional factors are involved in the regulation of TLR4 expression under hypoxia. Our results now show that TLR4 expression can be transcriptionally regulated by HIF-1 in macrophages under hypoxic conditions, and our ChIP assays revealed that HIF-1a binds to the TLR4 promoter. Moreover, the proximal promoter region of mouse TLR4 contains a putative HRE (5 0 -CGTG-3 0 ) located at ) 407 to ) 404, and the human TLR4 promoter contains at least two putative HREs located at ) 2811 to ) 2814 and ) 1185 to ) 1188 according to an analysis of the human Tlr4 gene (UCSC Genome Browser, accession no. uc004bjz1). Mutation of the CGTG to AAAG, or deletion of the CGTG region, led to a significant reduction of TLR4 promoter reporter activity in response to HIF-1a over-expression, showing that this site is important for HIF-1-mediated TLR4 expression. Overexpression of HIF-1a increased TLR4 mRNA and promoter activity in macrophages under hypoxic conditions, but not under normoxic conditions, possibly because of the rapid degradation of HIF-1a when oxygen is abundant. It has been reported that HIF-1a can be increased by LPS, contributing to LPS-induced sepsis symptomatology and lethality. 28 Together with our results, these suggest that LPS-induced HIF-1a activation and HIF-1a-mediated TLR4 expression can elicit a positive feedback loop to augment macrophage activation. Indeed, hypoxia enhances the phagocytic and microbicidal functions of macrophages. 29 Our results also demonstrate that the responsiveness of macrophages to bacterial components is increased when cells are pre-exposed to hypoxic stress, which possibly leads to enhanced cellular susceptibility to subsequent infection. Rosenberger et al. reported that netrin-1 can be induced in an HIF-1a-dependent manner resulting in the attenuation of hypoxia-elicited inflammation. Hypoxia-mediated inflammation was enhanced in Ntn1 +/) mice as compared with wild-type mice. 30 Netrin-1 may therefore play a role as a feedback inhibitor to attenuate hypoxia-elicited inflammation. Together with our results, these indicate that the activities of pro-inflammatory (TLR4) and anti-inflammatory (netrin-1) mediators can be regulated at the expression level by environmental stress such as hypoxia, leading to the dynamic modulation of susceptibility to infection and subsequent inflammatory and immune responses.
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